Skip to main content

Ceftazidime/Avibactam IV

Permitted Indications

Adults, adolescents and children aged 3 months and older for the treatment of the following infections:

  • complicated intra-abdominal infection (cIAI)
  • complicated urinary tract infection (cUTI), including pyelonephritis
  • hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP)
  • infections due to aerobic Gram-negative organisms in patients with limited treatment options

For the treatment of severe drug-resistant infections caused by gram-negative bacteria, including, but not limited to, infections caused by OXA-48 carbapenemase-producing Enterobacterales:

  • only on the advice of a Consultant/Specialist Microbiologist or infectious disease specialist and,
  • only if the infection is susceptible to ceftazidime/avibactam and not susceptible to other suitable antibiotics; or if susceptibility results are not available but the infection needs urgent treatment and is expected to be susceptible to ceftazidime/avibactam but not to other suitable antibiotics